PureTech Founded Entity Vor Biopharma Announces Pricing of Initial Public Offering
PureTech Founded Entity Vor Biopharma Announces Pricing of Initial Public Offering PureTech Founded Entity Vor Biopharma Announces Pricing of Initial Public Offering PureTech Health plc (LSE: PRTC, NASDAQ: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, is pleased to note that its Founded Entity, Vor Biopharma, has announced the pricing of its initial public offering (IPO) of 9,828,017 shares of common stock at a pu...